Genome-Wide Serum microRNA Expression Profiling Identifies Serum Biomarkers for Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2014-05-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3233/JAD-132144PMID 24577456
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating miR-125b as a biomarker of Alzheimer's disease.

  2014cited by this paper
• The future of blood‐based biomarkers for Alzheimer's disease

  2014cited by this paper
• Refining diagnostic microRNA signatures by whole-miRNome kinetic analysis in acute myocardial infarction.

  2013cited by this paper
• Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis

  2013cited by this paper
• A blood based 12-miRNA signature of Alzheimer disease patients

  2013cited by this paper
• Blood and plasma-based proteomic biomarker research in Alzheimer's disease.

  2013cited by this paper
• Ushering in the study and treatment of preclinical Alzheimer disease

  2013cited by this paper
• Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems

  2013cited by this paper
• MicroRNAs in the atherosclerotic plaque.

  2013cited by this paper
• Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer.

  2012cited by this paper
• Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.

  2012cited by this paper
• Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma

  2012cited by this paper
• Molecular network of microRNA targets in Alzheimer's disease brains.

  2012cited by this paper
• Use of circulating microRNAs to diagnose acute myocardial infarction.

  2012cited by this paper
• Non-coding RNAs in Alzheimer's Disease

  2012cited by this paper
• Plasma microRNA biomarkers for detection of mild cognitive impairment

  2012cited by this paper
• MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.

  2012cited by this paper
• Blood-based protein biomarkers for diagnosis of Alzheimer disease.

  2012cited by this paper
• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• 2011 Alzheimer's disease facts and figures

  2011cited by this paper
• MicroRNA-137/181c Regulates Serine Palmitoyltransferase and In Turn Amyloid β, Novel Targets in Sporadic Alzheimer's Disease

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Analysis of circulating microRNA: preanalytical and analytical challenges.

  2011cited by this paper
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Circulatory miR-34a as an RNA-based, noninvasive biomarker for brain aging

  2011cited by this paper
• The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Alzheimer's disease biomarker discovery in symptomatic and asymptomatic patients: experimental approaches and future clinical applications.

  2010cited by this paper
• Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

  2010cited by this paper
• Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma.

  2010cited by this paper
• A serum protein-based algorithm for the detection of Alzheimer disease.

  2010cited by this paper
• Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease

  2009cited by this paper
• Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease

  2009cited by this paper
• Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

  2008cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• MicroRNA Expression in Alzheimer Blood Mononuclear Cells

  2007cited by this paper
• KEGG for linking genomes to life and the environment

  2007cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• Real-Time Quantitative PCR

  2002cited by this paper
• Real time quantitative PCR.

  1996cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Open Access Molecular Neurodegeneration Upregulation of Mirna Hsa-mir-342-3p in Experimental and Idiopathic Prion Disease

  year unknowncited by this paper
• of Serum

  year unknowncited by this paper

• Brain-derived extracellular vesicles potentially mediate crosstalk with peripheral organs in neurodegenerative diseases

  2026cites this paper
• Nanotechnology-Enhanced MicroRNAs for Improved Diagnosis and Treatment of Major Depressive Disorder: A Comprehensive Review

  2025cites this paper
• Self-assembled DNA micelle-GNP for simultaneous detecting miRNAs of Alzheimer's disease via lateral flow assays.

  2025cites this paper
• ECL-CRISPR array for multiplexed detection of miRNAs.

  2025cites this paper
• Common miRNAs, Genes, and Regulatory Pathways in Alzheimer's Disease and Type 2 Diabetes Mellitus: An Integrative Analysis of Systematic Reviews, Bioinformatics and Data Mining

  2025cites this paper
• IsomiR utility in amyotrophic lateral sclerosis prognostication.

  2025cites this paper
• MicroRNA Dysregulation in Neurodegeneration: Role, Biomarker Potential, and Therapeutics.

  2025cites this paper
• Insights From a Scoping Review and Bibliometric Analysis of Trends and Advances in Biomarker Research: The Role of MicroRNAs in Cognitive Decline Across Neurodegenerative Diseases

  2025cites this paper
• A plasma miRNA signature, including miR‐495, as early diagnostic biomarkers associated with cognitive decline in Alzheimer's disease

  2025cites this paper
• Investigation of the role of miRNA variants in neurodegenerative brain diseases

  2025cites this paper
• Unlocking the Therapeutic Promise of miRNAs in Promoting Amyloid-β Clearance for Alzheimer's Disease.

  2025cites this paper
• "Multi-Omics Integration and Machine Learning Reveal Biomarker Networks and Therapeutic Targets in Alzheimer’s Disease"

  2025cites this paper
• IsomiR Utility in Amyotrophic Lateral Sclerosis Prognostication

  2025cites this paper
• In silico detection of dysregulated genes and molecular pathways in Alzheimer’s disease as basis for food restoring approach

  2025cites this paper
• Plasma miRNAs across the Alzheimer's disease continuum: Relationship to central biomarkers

  2024cites this paper
• Unveiling the Complex Role of Exosomes in Alzheimer’s Disease

  2024cites this paper
• Sex-associated microRNAs potentially implicated in sporadic Alzheimer's disease (sAD).

  2024cites this paper
• The potential diagnostic accuracy of circulating microRNAs for Alzheimer's disease: A meta-analysis.

  2024cites this paper
• The role of exosomal molecular cargo in exosome biogenesis and disease diagnosis

  2024cites this paper
• Exosomal Dynamics and Brain Redox Imbalance: Implications in Alzheimer’s Disease Pathology and Diagnosis

  2024cites this paper
• Effects of a High-Fat Diet on Insulin-Related miRNAs in Plasma and Brain Tissue in APPSwe/PS1dE9 and Wild-Type C57BL/6J Mice

  2024cites this paper
• ADVANCES IN ALZHEIMER'S DISEASE: A MULTIFACETED REVIEW OF POTENTIAL THERAPIES AND DIAGNOSTIC TECHNIQUES FOR EARLY DETECTION.

  2024cites this paper
• The potential of five c-miRNAs as serum biomarkers for Late-Onset Alzheimer's disease diagnosis: miR-10a-5p, miR-29b-2-5p, miR-125a-5p, miR-342-3p, and miR-708-5p.

  2024cites this paper
• MiRNA let-7d-5p Alleviates Inflammatory Responses by Targeting Map3k1 and Inactivating ERK/p38 MAPK Signaling in Microglia.

  2024cites this paper
• The Role of Transposable Elements in Long-Term Memory Formation

  2024cites this paper
• A hypothesis about interrelations of epigenetic factors and transposable elements in memory formation

  2024cites this paper
• The plasma miRNAome in ADNI: Signatures to aid the detection of at‐risk individuals

  2024cites this paper
• Involvement of transposable elements in Alzheimer’s disease pathogenesis

  2024cites this paper
• Circulating microRNA miR-425-5p Associated with Brain White Matter Lesions and Inflammatory Processes

  2024cites this paper
• Omnipresence MicroRNA-483: A comprehensive organ by organ literature review

  2023cites this paper
• Cerebrovascular miRNAs Track Early Development of Alzheimer’s Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation

  2023cites this paper
• miRNA as an Ultimate and Emerging Diagnostic Approach for the Detection of Alzheimer's Disease.

  2023cites this paper
• A new perspective on Alzheimer’s disease: microRNAs and circular RNAs

  2023cites this paper
• The dysregulation of miRNAs in epilepsy and their regulatory role in inflammation and apoptosis

  2023cites this paper
• miR‐6076 targets BCL6 in SH‐SY5Y cells to regulate amyloid‐β‐induced neuronal damage

  2023cites this paper
• MiRNA a New Insight in Metabolic and Human Diseases: A Review.

  2023cites this paper
• MicroRNAs and MAPKs: Evidence of These Molecular Interactions in Alzheimer’s Disease

  2023cites this paper
• Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease

  2023cites this paper
• Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease

  2023cites this paper
• Role of miRNAs in Neurodegeneration: From Disease Cause to Tools of Biomarker Discovery and Therapeutics

  2022cites this paper
• Let-7c increases BACE2 expression by RNAa and decreases Aβ production.

  2022cites this paper
• Microglial activation in Alzheimer's disease: The role of flavonoids and microRNAs

  2022cites this paper
• Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training

  2022cites this paper
• Extracellular Vesicles Derived From Plasma of Patients With Neurodegenerative Disease Have Common Transcriptomic Profiling

  2022cites this paper
• CEND1 and MIR885 methylation changes associated with successful cognitive aging in community-dwelling older adults.

  2022cites this paper
• Sporadic Alzheimer’s Disease- and Neurotoxicity-Related microRNAs Affecting Key Events of Tau-Driven Adverse Outcome Pathway Toward Memory Loss

  2022cites this paper
• Circ_0003611 acts as a miR-885-5p sponge to aggravate the amyloid-β-induced neuronal injury in Alzheimer’s disease

  2022cites this paper
• Alzheimer ' s Disease Tests-Medical Clinical Policy Bulletins

  2022cites this paper
• Effect of Letrozole on hippocampal Let-7 microRNAs and their correlation with working memory and phosphorylated Tau protein in an Alzheimer's disease-like rat model

  2022cites this paper
• MiR-191-5p Attenuates Tau Phosphorylation, Aβ Generation, and Neuronal Cell Death by Regulating Death-Associated Protein Kinase 1.

  2022cites this paper
• RNA-Seq Profiling of Neutrophil-Derived Microvesicles in Alzheimer’s Disease Patients Identifies a miRNA Signature That May Impact Blood–Brain Barrier Integrity

  2022cites this paper
• The role of microRNA-485 in neurodegenerative diseases

  2022cites this paper
• Exosomes: A bridge of periodontitis and systemic diseases

  2022cites this paper
• Blood-Based miRNA Biomarkers as Correlates of Brain-Based miRNA Expression

  2022cites this paper
• Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview

  2022cites this paper
• MiR‐483‐3p improves learning and memory abilities via XPO1 in Alzheimer's disease

  2022influential citation
• Nicotinic Acetylcholine Receptors and Microglia as Therapeutic and Imaging Targets in Alzheimer’s Disease

  2022cites this paper
• Traumatic MicroRNAs: Deconvolving the Signal After Severe Traumatic Brain Injury

  2022cites this paper
• The role of the microRNA regulatory network in Alzheimer’s disease: a bioinformatics analysis

  2021cites this paper
• The potential diagnostic accuracy of circulating microRNAs for Alzheimer's disease: A meta-analysis.

  2021cites this paper
• EFFECTS OF LETROZOLE ON MICRORNAS: IMPLICATIONS ON MEMORY AND ALZHEIMER’S DISEASE

  2021cites this paper
• Prediction of differentially expressed microRNAs in blood as potential biomarkers for Alzheimer’s disease by meta-analysis and adaptive boosting ensemble learning

  2021cites this paper
• Post‐transcriptional regulation of α7 nAChR expression by miR‐98‐5p modulates cognition and neuroinflammation in an animal model of Alzheimer's disease

  2021cites this paper
• The transcriptional landscape of Alzheimer's disease and its association with Wnt signaling pathway.

  2021cites this paper
• The Eminent Role of microRNAs in the Pathogenesis of Alzheimer's Disease

  2021cites this paper
• Extracellular RNA in Alzheimer’s disease

  2021cites this paper
• MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities

  2021cites this paper
• Current research status of blood biomarkers in Alzheimer's disease: diagnosis and prognosis.

  2021cites this paper
• MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer’s disease

  2021cites this paper
• The Emerging Role of Long Non-Coding RNAs and MicroRNAs in Neurodegenerative Diseases: A Perspective of Machine Learning

  2021cites this paper
• The biological significance and clinical utility of emerging blood biomarkers for traumatic brain injury.

  2021cites this paper
• Cerebrospinal Fluid MicroRNA Changes in Cognitively Normal Veterans With a History of Deployment-Associated Mild Traumatic Brain Injury

  2021cites this paper
• N-acetyl l-aspartate and Triacetin modulate tumor suppressor MicroRNA and class I and II HDAC gene expression induce apoptosis in Glioblastoma cancer cells in vitro.

  2021cites this paper
• Emerging Roles of Non-Coding RNA in Neuronal Function and Dysfunction

  2021cites this paper
• Effect of Letrozole on hippocampal let-7 microRNAs and their correlation with working memory and phosphorylated Tau protein level in an Alzheimer's disease rat model

  2021cites this paper
• Epigenetics of Alzheimer’s Disease

  2021influential citation
• Tripterygium wilfordii derivative LLDT-8 targets CD2 in the treatment of rheumatoid arthritis

  2021cites this paper
• Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach

  2020cites this paper
• Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease

  2020cites this paper
• MORONET: Multi-omics Integration via Graph Convolutional Networks for Biomedical Data Classification

  2020cites this paper
• Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease

  2020cites this paper
• Downregulated Platelet miR-1233-5p in Patients with Alzheimer’s Pathologic Change with Mild Cognitive Impairment is Associated with Aβ-Induced Platelet Activation via P-Selectin

  2020cites this paper
• MicroRNA Alterations in a Tg501 Mouse Model of Prion Disease

  2020cites this paper
• Role of circulating miR 194-5p, miR 106b, and miR 146a as potential biomarkers for epilepsy: a case-control study

  2020cites this paper
• The regulatory mechanism of miR-98-5p targeting ADAM15 on atherosclerotic plaque formation and vascular remodeling in mice with acute coronary syndrome through p38MAPK pathway

  2020cites this paper
• Diagnostic and prognostic value of microRNAs for Alzheimer’s disease: a comprehensive meta-analysis

  2020cites this paper
• Microfluidics-Based Systems in Diagnosis of Alzheimer’s Disease and Biomimetic Modeling

  2020cites this paper
• Differential Expression of Exosomal MicroRNAs in Neurodegenerative Diseases

  2020cites this paper
• Circulating MicroRNAs as Diagnostic Biomarkers of Clinical Cognitive Impairment: A Meta-Analysis

  2020cites this paper
• Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer’s and Parkinson’s Diseases

  2020cites this paper
• Circulating Exosome microRNAs as Diagnostic Biomarkers of Dementia

  2020cites this paper
• Neuronal Development-Related miRNAs as Biomarkers for Alzheimer's disease, Depression, Schizophrenia and Ionizing Radiation Exposure.

  2020cites this paper
• Differential Expression and miRNA–Gene Interactions in Early and Late Mild Cognitive Impairment

  2020cites this paper
• The current status of blood epigenetic biomarkers for dementia

  2019cites this paper
• miRNAs as Biological Markers in the Diagnosis and Treatment of Alzheimer’s Disease

  2019cites this paper
• Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer’s disease

  2019cites this paper
• Exosomes in Pathogenesis, Diagnosis, and Treatment of Alzheimer’s Disease

  2019cites this paper
• Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans

  2019cites this paper
• Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease

  2019cites this paper
• A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer’s Disease

  2019cites this paper